Platinum
Gold
-
Bristol Myers Squibb
Bristol Myers Squibb
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are motivated by the power of science, with a legacy of pursuing bold science across oncology, hematology, cardiovascular, immunology and neuroscience. We’re accelerating the development of new medicines with differentiated research platforms and leading technology to define what’s possible for the future of medicine and the patients we serve.
-
Idorsia Pharmaceutical Ltd
Idorsia Pharmaceutical Ltd
The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core. Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients.
-
Johnson & Johnson
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at www.innovativemedicine.jnj.com/emea/. Follow us at www.linkedin.com/jnj-innovative-medicine-emea for our latest news.
-
Schwabe Group
Schwabe Group
For over 150 years, Dr. Willmar Schwabe Pharmaceuticals has led the way in phytopharmaceuticals. Our products are the result of decades of cutting-edge research and experience. Manufactured to highest pharmaceutical quality and supported by comprehensive clinical evidence our herbal extracts are renown for their efficacy, safety, and tolerability. With a global workforce of over 3,500 individuals spanning five continents, we are dedicated to natural health products.
-
TEVA Pharmaceuticals Europe
TEVA Pharmaceuticals Europe
Teva aims to be a new kind of pharmaceutical company, liberated from the traditional definition of a generics company. We harness our generics expertise and innovate, driving the discovery, delivery, and development of modern medicine. We commit to delivering quality medicine, discovering life-changing treatments, and advancing scientific innovation. For us, good is not enough. Our legacy is to be stronger, bolder, and simpler, relentlessly growing by understanding what’s next in science, for patients, people, and society. We are all in for better health. Moving forward together with science that treats, inspired by the people we serve. We are Teva.
Silver
-
Gedeon Richter
Gedeon Richter
Richter aspires to be a global innovator in some key scientific fields, while dedicated to making medicines more accessible worldwide. Founded in 1901, headquartered in Hungary, it operates Central Europe’s largest R&D hub. Its research drives breakthroughs in Neuropsychiatry and Women’s Healthcare, while Biotechnology and General Medicines strengthen its affordable treatment portfolio. One of our latest achievements is the original antipsychotic, cariprazine, marketed in the US for bipolar disorder, schizophrenia and adjunctive treatment of major depressive disorder and in most of the European countries, many MENA countries, Australia, South-Africa and some Asian countries for treatment of schizophrenia in adult patients.
-
ROVI PHARMACEUTICAL COMPANY
ROVI PHARMACEUTICAL COMPANY
ROVI is a pan-European pharmaceutical company specialized and dedicated to the research, development, licensed manufacturing, and marketing of molecules and biological specialties. The company is undergoing continuous international expansion, with subsidiaries in Portugal, Germany, the United Kingdom, Italy, France, and Poland. It has a diversified portfolio of more than 40 marketed products. ROVI’s compromise with the improvement of people’s lives and health is visualized in their focus in R&D, focusing on the development the ISM® Platform technology in different therapeutic areas, a cutting-edge research line in the field of prolonged drug release with proven advantages.
Bronze
-
Eli Lilly and Company
Eli Lilly and Company
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Exhibitors
-
Abomics
Abomics
Abomics is a Finnish health-tech company specializing in pharmacogenetics (PGx). Founded in 2013 by medical doctors, we support healthcare professionals in making safer, more effective medication decisions by turning genetic data into actionable clinical insight.
Our pharmacogenetic solutions enable precision medication by identifying how individual genetic variation affects drug response and dosing. This reduces trial and error prescribing and lowers the risk of adverse drug reactions. Designed for real world healthcare settings, our solutions integrate seamlessly into existing clinical workflows, ensuring PGx information is available throughout a patient’s lifetime. -
AliveCor
AliveCor
AliveCor is a health tech company at the forefront of AI in cardiology. Our mission is to save lives and transform heart health.
We’ve made history by introducing multiple first-in-class, medical-grade AI solutions, backed by over 250 peer-reviewed articles, and have recorded over 350 million ECGs.
At the foundation of AliveCor’s technology is clinical AI, a powerful diagnostic intelligence that is already cleared to detect 39 different cardiac conditions, including life-threatening heart attacks and ischemias.
-
Brainsway
Brainsway
A global medical technology company, BrainsWay, focuses on developing cutting-edge medical devices that help advance the field of mental healthcare. Our advanced flagship technology, Deep Transcranial Magnetic Stimulation (Deep TMS™), is expanding the treatment of mental health beyond what was thought possible.
Deep TMS treatment has been proven to offer significant results by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression, late-life depression, obsessive-compulsive disorder, smoking addiction, and more.
-
Callyope
Callyope
Callyope is a clinical AI platform for psychiatry. We help mental health clinicians save medical time and deliver continuous, proactive care through automated documentation and voice-based patient monitoring.
Callyope’s technology is built on the first audio-language foundation model designed specifically for mental health, developed in partnership with leading clinical and research institutions.
-
Cambridge University Press
Cambridge University Press
Cambridge University Press is a not-for-profit publisher that dates from 1534 and is part of the University of Cambridge. Our mission is to unlock people’s potential with the best learning and research solutions by combining state-of-the-art content with the highest standards of scholarship, writing and production.
-
CEREBRUM VR SRL
CEREBRUM VR SRL
Cerebrum VR SRL is an innovative startup based in Rome that develops advanced Virtual Reality solutions for mental health and cognitive rehabilitation. By integrating neuroscience, psychology, and emerging technologies, the company delivers immersive and scientifically grounded tools for mental health professionals.
Through customizable and ecologically valid Virtual Reality applications, Cerebrum VR supports therapeutic and rehabilitative pathways, fostering the enhancement of cognitive, metacognitive, and psychosocial functions. Its mission is to modernize traditional clinical tools and approaches, improving treatment effectiveness and facilitating the transfer of therapeutic outcomes to everyday life.
-
DEYMED Diagnostic
DEYMED Diagnostic
DEYMED Diagnostic is a leading Czech company with an established global existence, specialising in advanced medical diagnostic and treatment technologies for neurophysiology and psychiatry. Founded in 1997, DEYMED has expanded its product range over the years to include EEG, EMG, TMS (Transcranial Magnetic Stimulation), PSG (Polysomnography), and BFB (Biofeedback) systems, trusted by healthcare providers worldwide for their precision, reliability, and ease of use.
Focusing on innovation and quality, DEYMED has become one of the leaders in both clinical and research applications. Its solutions are engineered for signal quality, multifunctionality and reliability with in-house development ensuring that all products meet healthcare standards. Each manufactured device undergoes strict testing to ensure safety and performance.
Through ongoing investment in R&D, DEYMED is pushing the boundaries of innovation in neurophysiology and psychiatry, improving patient outcomes and making progress in the field.
-
EAN
EAN
The European Academy of Neurology (EAN) is a non-profit organisation representing over 45,000 members and 48 national societies. It promotes excellence in neurology across Europe to improve patient care and strengthen scientific progress. EAN works to keep Europe at the forefront of neurological research and innovation. Its officers and leadership are renowned experts who volunteer their time to support the organisation, clinicians, researchers, and patients. EAN’s mission is to foster high standards in neurological practice, education, and research. By uniting Europe’s leading neurological professionals, the association aims to advance quality care and improve outcomes worldwide.
-
Electromedical Products International, Inc.
Electromedical Products International, Inc.
Alpha-Stim® is a drug-free, non-invasive, FDA-cleared medical device that offers rapid, safe, and highly effective treatment for anxiety and insomnia through cranial electrotherapy stimulation (CES) and pain relief through microcurrent electrical therapy (MET). Alpha-Stim delivers a patented waveform via mild microcurrents to the brain using earclip electrodes and directly targets the site of pain with handheld probes. Proven through extensive clinical research, Alpha-Stim is available over the counter in dozens of countries worldwide but requires a prescription in the US.
Notably, Alpha-Stim provides a user-friendly treatment option that can be administered in-office or at home, outperforming more expensive and cumbersome alternatives. It can be used as a standalone therapy, in conjunction with other treatment modalities, or as a complement to medication, all without the risk of drug interactions. Alpha-Stim maintains an impeccable safety profile with no serious adverse effects and no risk of addiction.
-
EUFAMI
EUFAMI
EUFAMI was founded in 1992 after a congress, which took place in 1990 in De Haan, Belgium, where carers from all over Europe shared their experiences of helplessness and frustration when living with severe mental illness. They resolved to work together to help both themselves and the people they cared for. EUFAMI is a democratic organisation, registered in Belgium as an international non-profit organisation. We have an ongoing commitment to improving care and welfare for people affected by mental illness. We also enable our member organisations to act jointly at a European Level, combining their efforts and sharing experience.
-
European Brain Council
European Brain Council
The European Brain Council (EBC) is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
A non-profit organisation based in Brussels, its main mission is to promote brain research with the ultimate goal of improving the lives of the millions of Europeans living with brain conditions, mental and neurological alike.
With the aim to speak with one voice, EBC stands as the platform to foster cooperation between its member organisations and other stakeholders, consistently promoting dialogue between scientists, industry and society.
-
European College of Neuropsychopharmacology
European College of Neuropsychopharmacology
ECNP is Europe’s leading independent forum for the science of CNS treatments.
The ECNP Congress showcases the world’s best disease-oriented brain research, annually attracting more than 7,600 psychiatrists, neuroscientists, neurologists and psychologists.
ECNP’s wide range of scientific and educational activities, programmes and events make it the largest non-institutional supporter of applied and translational neuroscience research and education in Europe.
-
European Federation of Psychiatric Trainees
European Federation of Psychiatric Trainees
The European Federation of Psychiatric Trainees (EFPT) is an independent, nonprofit, umbrella organization for European national psychiatric trainees’ associations. The organization currently represents psychiatric trainees from more than thirty European countries (World Health Organization definition of Europe).
EFPT’s vision is to cultivate a dynamic and inclusive environment that prioritizes the well-being, growth, and professional development of psychiatric trainees.
EFPT aims to create a community where high-quality training, mutual respect, and the continuous exchange of knowledge are fundamental principles, ensuring that trainees are well-equipped to address contemporary challenges in mental health care.
-
GAMIAN
GAMIAN
Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe), is a non-profit, patient-driven pan-European organisation, representing and advocating the interests and rights of persons affected by mental ill-health. Its principal activities relate to advocacy, information, awareness-raising, education, partnership and capacity building.
-
Luminette by Lucimed
Luminette by Lucimed
Lucimed combines optical technology and chronobiology to provide portable, high-performance solutions aimed at regulating the internal biological clock and improving daily vitality. Their products are designed to address specific conditions such as:
– Seasonal Affective Disorder (“winter blues”)
– Sleep disorders and insomnia
– Jet lag
– Fatigue related to night shift work.Their flagship product is the Luminette, a pair of light therapy glasses.
-
MagVenture
MagVenture
MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. Privately-owned and headquartered in Denmark, MagVenture has been pioneering cutting-edge magnetic stimulation solutions for more than 30 years. MagVenture’s TMS and mPNS systems are used for a wide range of applications in both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation. MagVenture’s vision is to offer new hope to patients by transforming how mental health and physical conditions are treated. Our mission is to pioneer safe, effective, and reliable magnetic stimulation therapies, offer innovative and versatile research solutions and work to expand access to magnetic stimulation worldwide. MagVenture’s products are available on the global market through direct sales subsidiaries in the USA, Germany, the UK, China, and Brazil, and through a global network of distributors.
-
Medicteit
Medicteit
Medicteit is building AI-powered virtual patients for medical education and clinical communication training. Our web-based platform lets students and trainees practise diagnostic interviews, clinical reasoning, and documentation through realistic, interactive cases with structured feedback—without local installation and with minimal IT burden. Institutions can deploy cohorts quickly, monitor progress via an admin dashboard, and integrate sessions into existing curricula. We are expanding multilingual support and specialty modules in collaboration with European partners.
-
Nanjing Healed Gene Biotechnology Co., Ltd.
Nanjing Healed Gene Biotechnology Co., Ltd.
Nanjing Healed Gene Biotechnology Co., Ltd. is partially owned by Jiangsu Southeast University Asset Management Co., Ltd., and mainly focuses on manufacturing depression tests.
Healed Gene Depression Test (CE certified)
- Detects depression (yes/no)
- Classifies severity (mild, moderate, or severe)
- Evaluate treatment efficacy (SSRIs/SNRIs, rTMS, Ketamine, ECT)
The test details are as below,
- Test sample: 3ml blood or 3ml saliva
- Depression biomarkers: 4 Circular RNA genes
- Test method: qPCR process in laboratory
-
neurocare group AG
neurocare group AG
neurocare group AG offers a best-practice mental health platform, enabling clinicians to provide personalized therapy with sustainable outcomes for psychological and neurological conditions. The platform includes in-house-developed technology for non-invasive brain stimulation via TMS and tDCS, neurofeedback, QEEG, a cloud-based software, as well as an online academy for detailed training of all modalities. Our solutions are used in our clinics in Europe, the US, Australia, and a growing number of third-party clinics.
At EPA-2026 we introduce our latest development in Neurofeedback – the bluetooth amplifier and highly engaging software neurocare SAM.
Visit us to learn how you can enhance your therapy outcomes with state-of-the-art neuromodulation or discuss your options for joining our clinics network.
-
PAREA
PAREA
PAREA (Psychedelic Access and Research European Alliance) is a non-profit, multi-stakeholder, pan-European partnership dedicated to improving mental health innovation and care. PAREA brings together researchers, clinicians, patient advocates, and psychedelic organisations to advance and responsibly translate psychedelic research into real-world care. Working at the intersection of policy, advocacy and education, PAREA acts as a systems-level catalyst for the safe, equitable, and people-centred development and integration of psychedelic-assisted care into European health systems, making psychedelic therapies accessible and reimbursed to those who need them and supporting a future where mental health and wellbeing are central to daily life and human flourishing.
-
Pineapple Contracts
Pineapple Contracts
We design purpose-built furniture to transform challenging environments, from mental health facilities to schools. We deliver tailored solutions that prioritise safety, comfort, and functionality. Every detail is thoughtfully considered for peace of mind.
Discover how we can support your goals globally, offering guidance and practical solutions to improve safety, enhance comfort, and optimise space in your environment.
Visit our stand to meet our team, discover innovative, safe furniture solutions, and see how we can support your goals worldwide.
-
Resilience Psychiatry
Resilience Psychiatry
Resilience Psychiatry is a remote monitoring solution dedicated to mood disorders. It includes a monitoring platform for healthcare professionals (CE Class IIa certified MD) that allows them to evaluate the effectiveness of treatments using PRO data, and a mobile app that helps patients measure their symptoms and access appropriate resources. Resilience Psychiatry is developed by the company Resilience Care, whose solutions in oncology, gastroenterology, and psychiatry are deployed to more than 23,000 patients in 150 healthcare institutions. The company puts data at the service of care and therapeutic innovation for personalized medicine.
-
SEBERS Medical
SEBERS Medical
SEBERS Medical makes TMS easy!
SEBERS Medical is a privately owned medical technology company with offices in Germany and the United States, dedicated to the development and global distribution of advanced Transcranial Magnetic Stimulation (TMS) systems for therapeutic use.
We design and deliver state-of-the-art TMS devices for the treatment of neuropsychiatric disorders, combining clinical performance with ease of use. Our Blossom TMS™ therapy platform is complemented by smart, patented innovations such as the TMS Pilot™ coil-mounted positioning display and the HeadNest™ head positioning system, enabling fast, precise, and reproducible treatments.
SEBERS Medical TMS solutions are trusted by clinics and research centers and are available in more than 30 countries worldwide.
-
STORZ MEDICAL AG
STORZ MEDICAL AG
STORZ MEDICAL AG, founded in 1987 and located on the Swiss shore of Lake Constance in Tägerwilen, develops and manufactures innovative shock wave systems and devices of the highest precision. We present the non-invasive Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system, approved since 2018 for the treatment of patients with Alzheimer’s disease. The acoustic pulses generated by the NEUROLITH® system have been used in medicine since 1990 to treat various conditions and are referred to as extracorporeal shock waves. Furthermore, the BodyTrack® software integrated in the NEUROLITH®, together with the dedicated camera, represents a unique tool for visualising and monitoring the emitted TPS pulses and the course of treatment.
-
The International Prader-Willi Syndrome Organisation
The International Prader-Willi Syndrome Organisation
The Internatoinal Prader-Willi Syndrome Organisation (IPWSO) works to achieve a world where people with Prader-Willi syndrome (PWS) and their families receive the support they need to fulfil their potential. We do this by working with families, professionals and researchers from around the world, helping to link peope together and inspire them to share knowledge about how best to manage PWS.
-
Wisepress Medical Bookshop
Wisepress Medical Bookshop
Visit the Wisepress stand to view our extensive range of books and journals relevant to this conference. We work with multiple publishers to ensure that our books are the best available in your specialism.
Wisepress.com is Europe’s leading conference bookseller, attending 150 conferences a year with titles also available on our online bookshop at www.wisepress.com.
Want to make a bulk order? Contact us via email.